MORISHITA JINTAN CO.,LTD. Logo

MORISHITA JINTAN CO.,LTD.

Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.

4524 | T

Overview

Corporate Details

ISIN(s):
JP3924400009
LEI:
Country:
Japan
Address:
大阪市中央区玉造一丁目2番40号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1893, Morishita Jintan Co., Ltd. is a multifaceted healthcare company engaged in the manufacture and sale of health-related products. The company's portfolio includes pharmaceuticals, quasi-drugs, medical devices, cosmetics, and health foods such as dietary supplements and probiotics. It is well-known for its 'Jintan' brand of oral care products. In addition to its direct-to-consumer offerings, Morishita Jintan provides Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services for the pharmaceutical and food industries, utilizing its expertise in advanced encapsulation technology to deliver high-quality, innovative healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:34
Registration Form
確認書
Japanese 8.2 KB
2025-11-12 07:32
Interim Report
半期報告書-第89期(2025/04/01-2025/09/30)
Japanese 172.4 KB
2025-06-26 06:56
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-06-20 08:44
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 08:41
Governance Information
内部統制報告書-第88期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-20 08:35
Annual Report
有価証券報告書-第88期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-12 07:15
Interim Report
半期報告書-第88期(2024/04/01-2025/03/31)
Japanese 179.7 KB
2024-11-12 07:13
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-06-27 04:45
Post-Annual General Meeting Information
臨時報告書
Japanese 24.9 KB
2024-06-26 06:23
Registration Form
確認書
Japanese 8.1 KB
2024-06-26 06:22
Governance Information
内部統制報告書-第87期(2023/04/01-2024/03/31)
Japanese 22.2 KB
2024-06-26 06:21
Annual Report
有価証券報告書-第87期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-08 05:32
Regulatory News Service
確認書
Japanese 8.1 KB
2024-02-08 05:31
Quarterly Report
四半期報告書-第87期第3四半期(2023/10/01-2023/12/31)
Japanese 162.1 KB
2023-11-09 05:31
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all MORISHITA JINTAN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MORISHITA JINTAN CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MORISHITA JINTAN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alkaloid AD Logo
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia
ALK
Alkermes plc. Logo
Develops medicines for CNS disorders like schizophrenia, bipolar, and sleep disorders.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
Develops personalized cancer drugs using a diagnostic platform to predict patient response.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom
AGY
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Developing off-the-shelf CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain
ALM
ALNYLAM PHARMACEUTICALS, INC. Logo
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
Alpha Cognition Inc. Logo
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG

Talk to a Data Expert

Have a question? We'll get back to you promptly.